Research graph
References from Evaluating the efficacy of the praziquantel dose pole for schistosomiasis treatment: A multi-country systematic review. Local targets link to admitted publications; unresolved targets remain external evidence.
Schistosomiasis
10.1038/s41572-018-0013-8 · 2018 · External reference
Unresolved reference
External reference
Unresolved reference
2022 · External reference
Unresolved reference
2020 · External reference
Diagnosis and management of schistosomiasis
2011 · External reference
Examining the relationship between urogenital schistosomiasis and HIV infection
10.1371/journal.pntd.0001396 · 2011 · External reference
Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance
10.1128/aac.02582-16 · 2017 · External reference
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial
10.1086/651682 · 2010 · External reference
Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island
2010 · External reference
Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children
10.1371/journal.pone.0006732 · 2009 · External reference
Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger
10.1016/j.actatropica.2012.08.008 · 2013 · External reference
Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon
10.1016/j.actatropica.2013.06.007 · 2013 · External reference
Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
10.1186/s12879-020-05053-z · 2020 · External reference
Schistosomiasis control: praziquantel forever?
10.1016/j.molbiopara.2014.06.002 · 2014 · External reference
Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy
10.1371/journal.pntd.0009189 · 2021 · External reference
Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis
10.1016/s0035-9203(99)90087-1 · 1999 · External reference
The WHO dose pole for the administration of praziquantel is also accurate in non-African populations
10.1016/j.trstmh.2004.06.006 · 2005 · External reference
Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole
10.1016/j.inhe.2010.02.003 · 2010 · External reference
Development and validation of a “tablet pole” for the administration of praziquantel in sub-Saharan Africa
10.1016/s0035-9203(01)90034-3 · 2001 · External reference
Field test of the “dose pole” for praziquantel in Zanzibar
10.1016/s0035-9203(02)90111-2 · 2002 · External reference
Accuracy of the WHO praziquantel dose pole for large-scale community treatment of urogenital schistosomiasis in northern Mozambique: Is it time for an update?
10.1371/journal.pntd.0006957 · 2018 · External reference
Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d’Ivoire and Kenya: an open-label, partly randomised, phase 3 trial
10.1016/s1473-3099(23)00048-8 · 2023 · External reference
Dosing of praziquantel by height in sub-Saharan African adults
10.4269/ajtmh.13-0252 · 2014 · External reference
The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa
10.1371/journal.pntd.0004623 · 2016 · External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · External reference
Unresolved reference
External reference
Field testing of the WHO dose pole for administration of praziquantel in the treatment of opisthorchiasis in Lao PDR
10.1016/j.trstmh.2007.07.004 · 2007 · External reference
Implementation of mass drug administration for neglected tropical diseases in Guinea during the COVID-19 pandemic
10.1371/journal.pntd.0009807 · 2021 · External reference
Discovery of a Hidden Schistosomiasis Endemic in the Salamat Region of Chad, Africa
10.9745/ghsp-d-20-00703 · 2022 · External reference
From a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium
10.3402/gha.v7.25351 · 2014 · External reference
Validating the WHO dose pole in the Philippines for school-based mass drug administration of praziquantel for morbidity control of schistosomiasis
10.1093/trstmh/trt076 · 2013 · External reference
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
10.1186/1756-3305-4-201 · 2011 · External reference
Unresolved reference
2024 · External reference
Global gender disparities in obesity: a review
10.3945/an.112.002063 · 2012 · External reference
Correction: Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
10.1371/journal.pntd.0008725 · 2020 · External reference
Overweight and obesity epidemic in developing countries: a problem with diet, physical activity, or socioeconomic status?
10.1155/2014/964236 · 2014 · External reference
Ivermectin dose assessment without weighing scales
1993 · External reference
